Omixon | GenomeWeb

Omixon

The funding is part of a Small Business Research Initiative competition to promote the development of new technologies to advance the diagnostic application of genomic screening.

NEW YORK (GenomeWeb) – Omixon today said it is collaborating with the Global Genomics Group to validate Omixon's Target HLA software to determine HLA genotypes from whole-genome sequencing datasets.

NEW YORK (GenomeWeb) – Next-generation sequencing interpretation firm Omixon plans to launch its first kit, a research-use HLA kit based on the clinical service offering at the Children's Hospital of Philadelphia.

This article has been corrected to list all of the genes targeted by the assay. The previous version noted only one of them.

NEWYORK (GenomeWeb) – Hungarian bioinformatics company Omixon said this week that it has opened an office in Cambridge, Mass. and raised an undisclosed amount of money that it will use to establish and grow its US-based sales, support, and product training team.

NEW YORK (GenomeWeb) – The UK Department of Health has announced the eight winners of the first round of a Small Business Research Initiative (SBRI) competition that’s focused on developing technologies for analyzing and interpreting sequence data for the 100K Genomes Project.

Paired Ends: Tim Hague

Premium

Genomics data analysis developer Omixon said this week that it has named Tim Hague as CEO, taking over for Founder Attila Berces, who will continue to serve as chairman of the board of directors.

NEW YORK (GenomeWeb News) – Knome has announced that its services division will now offer Omixon's targeted human leukocyte antigen typing capabilities as part of its whole genome and exome interpretation pipelines.

The UCSC Genome Browser group has released four tracks for the human assembly derived from dbSNP 137.

Cautious optimism seems to be the prevailing mood among some of the bioinformatics vendors that have signed up to develop analysis tools for Illumina’s BaseSpace applications store.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.